Water

Water

SCHEMBL2929026

CC(C)OC(C)C.O

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABCC9ABL1ACEACHEACVR1ADORA1ADORA2AADORA2BADORA3ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALOX5ATP4AATP4BBCRBTKCACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGCRBNCUL4ACXCR1CXCR2DDB1DDCDHFRDPP4DRD2DRD3DRD4EGFRERBB2ERBB4ESR1ESR2FDPSFKBP1AFLT1FLT3FLT4GARTGHSRGRIA1GRIA2GRIA3GRIA4GRIK1GRIK2GRIK3GRIK4GRIK5GRIN2AGSK3AGSK3BHDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IDH1IDH2IMPA1ITGA2BITGB3JAK1JAK2JAK3KCNJ11KCNK3KCNK9KDRKITMEN1METMMP1MMP13MMP7MMP8NANOD2NS5bODC1OPG057OPRD1OPRK1OPRM1PPARP1PARP2PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PKLRPPARDPPATPTGS1PTGS2RBX1ROCK1ROCK2RRM1RRM2RRM2BSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC10A2SLC5A2SLC6A2SLC6A3SLC6A4SLC9A3SYKTACR1THRATHRBTOP1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYK2TYMSVDRampCblablaT-3blaT-4blaT-5blaT-6blaUOE-1dacAdacBdacCfolAfolPftsIgyrAgyrBileSmecAmrcAmrcBmrdAparCparEpbp2pbp4pbpApbpFrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUthyAykgMykgO

The experimentally established mechanism targets of Water. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Water SCHEMBL7492545 1.00
Water SCHEMBL2473448 1.00
SCHEMBL1331944 0.94
SCHEMBL27912512 0.94 MAPK1 (0.31)
SCHEMBL7240952 0.94
SCHEMBL1296 0.94
SCHEMBL10940023 0.94
Methyl Alcohol SCHEMBL12474241 0.91 TSHR (0.32)
SCHEMBL14973371 0.89
SCHEMBL16345057 0.89

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115960750-A Baeyer-Villiger monooxygenase, mutant and application thereof in preparation of chiral butyrolactone 华东理工大学 2023-04-14 CN disclosed
CN-113321569-B Method for separating isopropyl ether, isopropyl alcohol and water by extractive distillation 烟台大学 2022-08-26 CN disclosed
US-9816147-B2 Liquid crystal based analyte detection PLATYPUS TECHNOLOGIES, LLC (US) 2017-11-14 US disclosed
US-20150203925-A1 LIQUID CRYSTAL BASED ANALYTE DETECTION PLATYPUS TECHNOLOGIES, LLC 2015-07-23 US disclosed
US-8988620-B2 Liquid crystal based analyte detection PLATYPUS TECHNOLOGIES, LLC (US) 2015-03-24 US disclosed
EP-1468691-B1 Use of bisphosphonates in the treatment of vascular restenosis YISSUM RES DEV CO (IL) 2010-06-16 EP disclosed
US-20100009344-A1 LIQUID CRYSTAL BASED ANALYTE DETECTION PLATYPUS TECHNOLOGIES, LLC (US) 2010-01-14 US disclosed
EP-1654390-B1 LIQUID CRYSTAL BASED ANALYTE DETECTION PLATYPUS TECHNOLOGIES LLC (US) 2009-11-11 EP disclosed
EP-1888781-A4 LIQUID CRYSTAL BASED ANALYTE DETECTION PLATYPUS TECHNOLOGIES LLC (US) 2009-01-21 EP disclosed
EP-1906963-A2 METHOD OF TREATING ISCHEMIA-REPERFUSION INJURY Biorest Ltd. (IL) 2008-04-09 EP disclosed
EP-1094820-A2 USE OF BISPHOSPHONATES IN THE TREATMENT OF VASCULAR RESTENOSIS YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) 2001-05-02 EP disclosed
WO-2000003677-A2 USE OF BISPHOSPHONATES IN THE TREATMENT OF VASCULAR RESTENOSIS YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) 2000-01-27 WO disclosed
EP-0345747-B1 Tricyclic compounds KYOWA HAKKO KOGYO KK (JP) 1996-06-26 EP disclosed
EP-0345747-A2 Tricyclic compounds KYOWA HAKKO KOGYO CO., LTD. (JP) 1989-12-13 EP disclosed
EP-0168976-B1 PROCESS FOR THE PRODUCTION OF AMINOPHENOLS SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1988-02-03 EP disclosed
US-4618665-A Process to prepare 2-phenylpropyl containing polydiorganosiloxanes DOW CORNING CORPORATION (US) 1986-10-21 US disclosed
US-4585896-A Process for the production of an aminophenol SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1986-04-29 US disclosed
EP-0168976-A1 Process for the production of aminophenols SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1986-01-22 EP disclosed
EP-0028665-B1 PROCESS FOR THE PRODUCTION OF DIARALKYLDICHLOROSILANES AND THEIR USE IN MANUFACTURE OF POLYSILOXANE Chisso Corporation (JP) 1983-05-18 EP disclosed
US-4269993-A Diaralkyldichlorosilanes CHISSO CORPORATION (JP) 1981-05-26 US disclosed